Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3903-3907

  Chang, Chao Hsiang ^a   Wang, Rou Fen ^a   Tsai, Ru Yin ^a   Wu, Hsi Chin ^a   Wang, Chung Hsing ^a   Tsai, Chia Wen ^a,b   Chang, Chia Lin ^a   Tsou, Yung An ^a   Liu, Chiu Shong ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; DNA repair; Single nucleotide polymorphism; XPD

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; ALLELE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TAIWAN;

ALLELES; CASE-CONTROL STUDIES; CODON; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; URINARY BLADDER NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 71949088452     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Department of Health, Taiwan. Cancer Registration System Annual Report. Taiwan, Department of Health, 2006.
2. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkström H, Larsson P, Kumar R and Hemminki K: Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25: 729-734, 2004. (Pubitemid 38618524)
3. Cohen SM, Shirai T and Steineck G: Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 205: 105-115, 2000. (Pubitemid 32056470)
4. Sakano S, Kumar R, Larsson P, Onelov E, Adolfsson J, Steineck G and Hemminki K: A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder. BJU Int 97: 847-851, 2005. (Pubitemid 43383526)
5. Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P and Matullo G: DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 65: 105-118, 2008. (Pubitemid 350036684)
6. Wei Q, Gu J, Cheng L, Bondy ML, Jiang H, Hong WK and Spitz MR: Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 56: 3975-3979, 1996. (Pubitemid 26284747)
7. Wolz L, Krause G and Scherer G: The comet assay with MCL-5 cells as an indicator of genotoxic treatment with chemicals and cigarette smoke condensates. Altern Lab Anim 30: 331-339, 2002. (Pubitemid 34815278)
8. Wallner BC, Harreus UA, Gamarra F, Sassen A and Kleinsasser NH: Mini-organ cultures of human nasal mucosa. A model for eco-genotoxicological investigations. HNO 53: 1037-1046, 2005.
9. Hung RJ, Hall J, Brennan P and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162: 925-942, 2005. (Pubitemid 41619464)
10. Goode EL, Ulrich CM and Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530, 2002. (Pubitemid 36020002)
11. Sancar A and Tang MS: Nucleotide excision repair. Photochem Photobiol 57: 905-921, 1993.
12. Weeda G and Hoeijmakers JH: Genetic analysis of nucleotide excision repair in mammalian cells. Semin Cancer Biol 4: 105-117, 1993.
13. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt SA, Arlett CF and Lehmann AR: Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 94: 8658-8663, 1997. (Pubitemid 27335095)
14. Shen MR, Jones IM and Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608, 1998.
15. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK and Bell DA: XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21: 551-555, 2000. (Pubitemid 30214005)
16. Xing D, Tan W, Wei Q and Lin D: Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 38: 123-129, 2002. (Pubitemid 35157754)
17. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR and Wei Q: XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 21: 2219-2223, 2000. (Pubitemid 32049228)
18. Tomescu D, Kavanagh G, Ha T, Campbell H and Melton DW: Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22: 403-408, 2001. (Pubitemid 32203818)
19. Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Bruning T and Brauch H: ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13: 2059-2064, 2004. (Pubitemid 40054298)
20. Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, Hsu Y, Schnabel F, Estabrook A and Perera FP: Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75: 159-166, 2002. (Pubitemid 34994951)
21. Romanowicz-Makowska H, Sobczuk A, Smolarz B, Fiks T and Kulig A: XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer. Pol J Pathol 58: 245-249, 2007.
22. Synowiec E, Stefanska J, Morawiec Z, Blasiak J and Wozniak K: Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648: 65-72, 2008.
23. Stern MC, Johnson LR, Bell DA and Taylor JA: XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1004-1011, 2002.
24. Gangwar R, Ahirwar D, Mandhani A and Mittal RD: Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India. Urology 73: 675-680, 2009.
25. Shao J, Gu M, Xu Z, Hu Q and Qian L: Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population. Cancer Genet Cytogenet 177: 30-36, 2007. (Pubitemid 47211297)
26. Sanyal S, De Verdier PJ, Steineck G, Larsson P, Onelov E, Hemminki K and Kumar R: Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol 46: 31-41, 2007.
27. Schabath MB, Delclos GL, Grossman, HB, Wang Y, Lerner SP, Chamberlain RM, Spitz MR and Wu X: Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 14: 878-884, 2005. (Pubitemid 40478551)
28. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
29. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang, CH, Wu CN, Lin CC and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902, 2008.
30. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF and Tsai FJ: Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27: 2893-2896, 2007.
31. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC and Tsai FJ: Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 27: 1559-1564, 2007. (Pubitemid 46807237)
32. Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai FJ, Lin CC and Bau DT: A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586, 2008. (Pubitemid 351672241)
33. Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, Wu CN, Liang SY, Wang CL, Tsai CW and Tsai MH: Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol 44: 1047-1051, 2008.
34. Chiu CF, Wang HC, Wang CH, Wang CL, Lin CC, Shen CY, Chiang SY and Bau DT: A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res 28: 267-270, 2008.
35. Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai FJ, Lin CC and Bau DT: A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586, 2008. (Pubitemid 351672241)
36. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A and Vineis P: DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92: 562-567, 2001. (Pubitemid 32319431)
37. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P and Porru S: Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 11: 1234-1240, 2003.
38. Bau DT, Mau YC, Ding SL, Wu PE and Shen CY: DNA double-strand-break repair capacity and risk of breast cancer. Carcinogenesis 28: 1726-1730, 2007. (Pubitemid 47289034)